Patents Assigned to Curatis AG
  • Mirtazapine for use in medication overuse headache based on tension-type headache
    Patent number: 11207330
    Abstract: Mirtazapine is useful for the treatment and/or prophylaxis of medication overuse headache based on tension-type headache. Moreover, a pharmaceutical composition and/or the use of mirtazapine for the manufacture of a medicament, are useful against medication overuse headache based on tension-type headache, and the treatment of medication overuse headache based on tension-type headache.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: December 28, 2021
    Assignees: Curatis AG, Rigshospitalet—Glostrup, The University of Copenhagen
    Inventors: Arnim Pause, Lars Bendtsen, Rigmor Jensen, Jes Olesen
  • Mirtazapine for use in medication overuse headache based on tension-type headache
    Publication number: 20210015828
    Abstract: Mirtazapine is useful for the treatment and/or prophylaxis of medication overuse headache based on tension-type headache. Moreover, a pharmaceutical composition and/or the use of mirtazapine for the manufacture of a medicament, are useful against medication overuse headache based on tension-type headache, and the treatment of medication overuse headache based on tension-type headache.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 21, 2021
    Applicants: Curatis AG, Rigshospitalet - Glostrup, The University of Copenhagen
    Inventors: Arnim PAUSE, Lars Bendtsen, Rigmor Jensen, Jes Olesen